OSHQOZON-ICHAK TRAKTI KASALLIKLARINI RATSIONAL FARMAKOTERAPIYASIDA H2 GISTAMIN RETSEPTOR BLOKATORLARINING SAMARADORLIGINI BAHOLASH

##plugins.themes.bootstrap3.article.sidebar##

PDF (English)
Nashr: Jild 6 Nomeri 4 : Евразийский журнал медицинских и естественных наук
Bo'lim: Статьи
##semicolon##
##submission.license.cc.by4.footer##

##plugins.themes.bootstrap3.article.main##

Andijan State Medical Institute, Department of Pharmacology, Clinical Pharmacology, and Medical Biotechnology
info@in-academy.uz

Abstrak:

Oshqozon-ichak trakti kasalliklari (gastrit, oshqozon va 12 barmoq ichak yarasi) dunyo bo‘ylab keng tarqalgan va jiddiy ijtimoiy-iqtisodiy oqibatlarga ega. Ushbu tadqiqotda H2 gistamin retseptor blokatorlarining farmakoterapiyada samaradorligi baholandi. Ishda bemorlarning klinik holati, shikoyatlari, laborator tekshiruvlari va endoskopik ma’lumotlari asosida davolash natijalari tahlil qilindi. Natijalar H2 blokatorlarining oshqozon shirasini sekretsiyasini samarali kamaytirishi, yara jarayonini tezlashtirishi va klinik simptomlarni kamaytirishi bilan bog‘liq ekanligini ko‘rsatdi. Tadqiqot natijalari oshqozon-ichak trakti kasalliklarini davolashda H2 blokatorlarining samaradorligini tasdiqlaydi va ularni ratsional farmakoterapiyada qo‘llashni asoslaydi.

##semicolon##

##plugins.themes.bootstrap3.article.details##

##submission.howToCite##:

Odiljonova , A. (2026). OSHQOZON-ICHAK TRAKTI KASALLIKLARINI RATSIONAL FARMAKOTERAPIYASIDA H2 GISTAMIN RETSEPTOR BLOKATORLARINING SAMARADORLIGINI BAHOLASH. Yevrosiyo Tibbiyot Va Tabiiy Fanlar Jurnali, 6(4), 113–118. Retrieved from https://in-academy.uz/index.php/EJMNS/article/view/78695

##submission.citations##:

Malfertheiner P., Chan F.K., McColl K.E.L. Peptic ulcer disease. Lancet. 2009;374:1449–1461.

Numonova G.D. Etiopathogenesis of gastrointestinal diseases. Multidisciplinary Journal of Science and Technology. 2025; Uzbekistan, ASMI.

Sobirjonov I.T. Specificity of treatment of peptic ulcer disease with H2 histamine blocker drugs. Multidisciplinary Journal of Science and Technology. 2025; Uzbekistan, ASMI.

Sachs G., Shin J.M. The pharmacology of H2-receptor antagonists. Aliment Pharmacol Ther. 2008;27:3–8.

Vakil N., et al. Gastroesophageal reflux disease: epidemiology and clinical features. Am J Gastroenterol. 2006;101:60–74.

Lanza F.L., et al. Guidelines for prevention of NSAID-induced ulcers. Am J Gastroenterol. 2009;104:728–738.

Baron T.H., et al. Peptic ulcer disease and H. pylori. N Engl J Med. 2010;362:1597–1608.